BCM Legacy Fund Eyes 15 Startups in 5 Years [2026]
Thursday, November 12, 2026 · first reported by shattered.io
Hogan Lovells Cadwalader advised on the formation of BCM Legacy Fund I, LP, a vehicle investing philanthropic capital in biomedical startups. The managers expect to back about 15 early-stage companies over five years, and the first investment went to Nemea Therapeutics.
- Firm
- BCM Legacy Fund
- Also named
- Hogan Lovells Cadwalader, Nemea Therapeutics, Inc.
- Fund
- BCM Legacy Fund I, LP
- Stage
- Launch
- Asset class
- Venture
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
See an error?
- Stage 2 Capital closes $100m across two venture funds targeting early-stage B2B AI companiesAltAssets
- Harwood hits £120M first close as British Business Bank adds £40M for SMEsDealroom +1
- Smart Capital enters industrial venture capital with €60M Levante II fundDealroom
- Ballistic Ventures eyes up to $490m across two new cybersecurity fundsAltAssets
- Enza Capital Reaches $21m First Close for AI Africa Fundiafrica.com +2
- Altimeter Wants $3.4 Billion For Venture Funds After Backing OpenAI And AnthropicBenzinga +2
Got news? Send it to us →